China Biotech Deal Volume Surged 81% as Western Pharma Doubles Down
A BIO China panel based on anonymous survey data from BD heads and senior dealmakers revealed that nearly 80%...
China licensing
A BIO China panel based on anonymous survey data from BD heads and senior dealmakers revealed that nearly 80%...